Bioelectronics Corp (BIEL)

[TruthBeSaid]

Sales Boom Continuing:

Happy New Year, everyone. The situation on Actipatch sales is a happy one too!

I had posted on-line sales numbers at Boots back in Nov (link). It is my pleasant duty to provide an update showing that the exponential growth is continuing, as seen below -

Since March 2104, when I started tracking, the sales have increased more than 10-fold, in three quarters. This is just on-line sales - the total sales including 2500 retails stores will be about a factor of 10 higher. My previous projections for sales and share prices stay about the same, see here - about 1c - 2c at a minimum and upto 10c or even higher possible briefly. I would like to suggest that the PPS lows we are hitting now will not last long and this is clearly a buying opportunity. The final rule announcement from FDA can come anytime. For those who are not in the know, FDA has proposed, on its own initiative, to reclassify the category of devices into which the actipatch products fall to the lower risk class II from class III. This is a reclassification Bielcorp has been seeking for sometime. The proposal to reclassify sent the stock price from a low of 0.0002 to 0.008 (40-fold). The comment period on the proposed rule ended in May and FDA is working in the final rule which can be announced anytime: see status page, shotwave diathermy, review of comments complete. Now, if the proposal to reclassify sent us up 40-fold, you can imagine what happens when the final rule is announced, I am predicting 1-2 c at a minimum. Further, if the final rule leaves the door open for over-the-counter sales, the pps uptick will be much bigger approaching 10c. The reclassification from FDA will allow the products to be marketed in the US and growth prospects are enormous - see the success in UK (Boots) shown in the chart above. I expect that the quarterly reports will start showing the effect of the booming sales numbers from the next report.

I am holding my position of 11 Million shares bought at an average price of 0.004, looking for ~ 5c. A slew of good news is lined up in the next few months:

FDA final rule : anytime now, possible OTC
501K sumbission : soon after
Sales numbers : latest by March, a company PR update possible anytime
FDA 501K clearance : a few months after submission.

The company now has good clinical trial results and at least one more has results due. Look at reviews at amazon.co.uk and at boots.com. See my previous posts for more information.. I and some of my friends and relatives have tried the product and it works, which is why I bought in.

Finally, do your DD and set up a position consistent with your risk tolerance. Don't take what I say - do your own thinking, I think I have provided sufficient information to make a decision. If you ask me, this is a golden opportunity for almost guaranteed gains, more than 10 fold for sure, very possibly 100-fold.

Forgot to add: I saw that they have started a tryactipacth campaign in Canada where they have OTC approval, as in UK. So, one can expect a similar story in Canada as in UK in the near future. I have checked boots stores in Ireland - it is possible to view in-store availabilty and as far as I have seen, they have it in every store I have checked. It is on the shelves in every store! This is not a typical pinksheet stock, this one has real products in shelves with demonstrable increasing sales and rave reviews. I am sure this is the case for UK stores too, but the website does not allow checking in-store availability. Finally, on amazon.co.uk, there are now multiple vendors carrying the product, I see three. I stopped tracking those as that will be too much work. You can see, though, that there are multiple sales channels.